ARTICLE | Company News
Medical Prognosis Institute, Alion deal
November 24, 2014 8:00 AM UTC
MPI will use its drug response predictor (DRP) to identify a predictive biomarker for selecting cancer patients likely to respond to an undisclosed ion channel inhibitor from Alion. The biomarker may ...